Abstract: In one example in accordance with the present disclosure, a method for assessing print quality is described. According to the method, a printed mark is converted into a digital binary mark. A number of values are calculated for the digital binary mark. The number of values include at least a perimeter length value and a value describing a characteristic of an intensity histogram for the digital binary mark. A combined representation of the number of values for the digital binary mark are compared against a combined representation of a number of values for a model printed mark. When the combined representation for the digital binary mark is greater than a predefined distance away from the combined representation for the model printed mark, an operation of a printing device that generated the printed mark is adjusted.

Abstract: In one example in accordance with the present disclosure, a method for assessing print quality is described. According to the method, a printed mark is converted into a digital binary mark. A number of values are calculated for the digital binary mark. The number of values include at least a perimeter length value and a value describing a characteristic of an intensity histogram for the digital binary mark. A combined representation of the number of values for the digital binary mark are compared against a combined representation of a number of values for a model printed mark. When the combined representation for the digital binary mark is greater than a predefined distance away from the combined representation for the model printed mark, an operation of a printing device that generated the printed mark is adjusted.

Abstract: Examples disclosed herein relate to determining data usage effectiveness. A processor may determine data usage effectiveness information related to an entity's workflow based on workflow data collected related to the entity's operations and metrics determined based on the data. The determination may be based on a comparison of the information related to the entity's workflow to target workflow information and priority information associated with the target workflow information. The processor may output information related to the determined data usage effectiveness.

Abstract: In one example, an augmented reality (AR) server. The server has an AR server program executable to transmit a first aura having a selectable weblink to a web-linked camera device (WLCD); receive from a website an identity that uniquely associates the WLCD with a user and aura data indicative of a second aura targeted to the user based on a user-selected weblink; and transmit the second aura to the WLCD corresponding to the identity.

Abstract: Examples disclosed herein relate to determining data usage effectiveness. A processor may determine data usage effectiveness information related to an entity's workflow based on workflow data collected related to the entity's operations and metrics determined based on the data. The determination may be based on a comparison of the information related to the entity's workflow to target workflow information and priority information associated with the target workflow information. The processor may output information related to the determined data usage effectiveness.

Abstract: In one example, an augmented reality (AR) server. The server has an AR server program executable to transmit a first aura having a selectable weblink to a web-linked camera device (WLCD); receive from a website an identity that uniquely associates the WLCD with a user and aura data indicative of a second aura targeted to the user based on a user-selected weblink; and transmit the second aura to the WLCD corresponding to the identity.

Abstract: In one example, an augmented reality aura having a selectable weblink is presented on web-linked camera device (WLCD). The WLCD is uniquely associated with a user.

Abstract: In one example, an augmented reality aura having a selectable weblink is presented on web-linked camera device (WLCD). The WLCD is uniquely associated with a user.

Abstract: A medication dispenser includes a thermal drop generator ejector head. Medication is maintained in a pressurized container connected to a valve under the control of control electronics and to a compliant chamber. Fluid flows from the container to the chamber and to the ejector head. In a first mode the dispenser is operable to dispense aerosolized medication. In a second mode the ejector head is purged with fluid from the container to maintain the ejector head.

Abstract: Systems, including apparatus and methods, for microfluidic processing and/or analysis of samples. The systems include a microfluidic device having a substrate and a thin-film layer formed on the substrate. The thin-film layer may be included in electronics formed on the substrate. The electronics may provide electronic devices configured to sense or modify a property of the sample. The thin-film layer defines an opening for routing movement of fluid and/or sample within the device.

Abstract: A method of making a pharmaceutically active ingredient abuse-prevention device includes providing a pharmaceutically active ingredient and providing an antagonist of the pharmaceutically active ingredient. The antagonist is in selective fluid communication with the pharmaceutically active ingredient. Electronic circuitry is configured to selectively operate the fluid communication between the antagonist and the pharmaceutically active ingredient so as to mix the pharmaceutically active ingredient with the antagonist upon recognition of one or more predetermined fault conditions. Mixing the pharmaceutically active ingredient with the antagonist renders the pharmaceutically active ingredient substantially ineffective.

Abstract: Inhaler systems and method of use thereof are disclosed. One exemplary inhaler system, among others, includes an inhalation/exhalation structure including an inhalation/exhalation orifice. In addition, the inhaler system includes a medicament supply system having a medicament ejector disposed adjacent the inhalation/exhalation orifice. The medicament supply system controllably ejects medicament droplets from the medicament ejector. Further, the inhaler system includes a flow control system in fluidic communication with the medicament ejector. The flow control system is configured to entrain the medicament droplets and pass the medicament droplets to the inhalation/exhalation orifice when the patient applies an in-breath to the inhalation/exhalation structure. In addition, the flow control system is configured to impede a flow of air from the inhalation/exhalation orifice to the medicament ejector when the patient applies an out-breath into the inhalation/exhalation structure.

Abstract: A microfluidic device for analysis of a sample. The microfluidic device includes a substrate portion that at least partially defines a chamber for receiving the sample. The substrate portion includes a substrate having a surface. The substrate portion also includes a plurality of thin-film layers formed on the substrate adjacent the surface. The thin-film layers form a plurality of electronic devices. Each of at least two of the electronic devices is formed by a different set of the thin-film layers.

Abstract: A medicament dispenser that includes a medicament supply, an ejector, and a controller configured to actuate the ejector, where the controller is configured to use an operational parameter to produce a plurality of medicament drops having a target drop characteristic, and the operational parameter includes a correction factor that is based on a performance characteristic of the ejector.

Abstract: An inhaler operable to control a temperature of a medicament of the inhaler includes a medicament reservoir being configured to store a medicament therein. A medicament ejector is operably coupled to the medicament reservoir and is configured to eject the medicament from the reservoir to deliver the medicament to a patient. A controllable thermal source is in thermal communication with at least an inside portion of the medicament reservoir and is operable to controllably affect a temperature of the medicament. A thermal control system is in operable communication with the controllable thermal source and is configured to control the thermal source to maintain the medicament within a predetermined temperature range.

Abstract: A microfluidic device for analysis of a sample. The microfluidic device includes a substrate portion that at least partially defines a chamber for receiving the sample. The substrate portion includes a substrate having a surface. The substrate portion also includes a plurality of thin-film layers formed on the substrate adjacent the surface. The thin-film layers form a plurality of electronic devices. Each of at least two of the electronic devices is formed by a different set of the thin-film layers.

Abstract: An inhalation system is disclosed that, in an exemplary embodiment, includes an ejector that ejects medicated droplets during an activation event, a conduit fluidically coupled to the ejector and configured to transport the droplets to a patient during an in-breath, and a particle detection system configured to determine whether the droplets have properly passed through the conduit and to the patient during an activation event. Also disclosed are methods for detecting particles in an inhaler system, with an exemplary method including generating a dose of medicament particles from an inhaler system; detecting particles emitted in the inhaler system; and determining if a desired particle flux has been achieved for inhalation by a patient.

Abstract: A microfluidic device for analysis of a sample. The microfluidic device includes a substrate portion that at least partially defines a chamber for receiving the sample. The substrate portion includes a substrate having a surface. The substrate portion also includes a plurality of thin-film layers formed on the substrate adjacent the surface. The thin-film layers form a plurality of electronic devices. Each of at least two of the electronic devices is formed by a different set of the thin-film layers. The at least two electronic devices may include 1) a temperature control device for controlling the temperature of fluid in the chamber, and 2) an other electronic device configured to sense or modify a property of fluid in the chamber.

Abstract: A silicon die having an orifice layer with plural openings formed therein defines a drop ejection device for use in a handheld inhaler. An underlying control layer defines fluid chambers, each carrying a heat transducer. A control system energizes selected heat transducers to heat fluid in the chambers, vaporizing the fluid, which is ejected through the orifices in small droplets.

Abstract: An inhaler operable to control a temperature of a medicament of the inhaler includes a medicament reservoir being configured to store a medicament therein. A medicament ejector is operably coupled to the medicament reservoir and is configured to eject the medicament from the reservoir to deliver the medicament to a patient. A controllable thermal source is in thermal communication with at least an inside portion of the medicament reservoir and is operable to controllably affect a temperature of the medicament. A thermal control system is in operable communication with the controllable thermal source and is configured to control the thermal source to maintain the medicament within a predetermined temperature range.